Biogen has started a phase 3 trial that it hopes will extend the label for its Skyclarys therapy for inherited neurological disease Friedreich's ataxia (FA) to include children as young as two.

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Facebook is the world's most successful social network — but it shows you an abject failure every time you open its app. One month in, no one's using "Stories," the Snapchat clone that sits on top of ...

Massive disruption to air travel: More than 5,300 U.S. flights have been canceled as a blizzard sweeps through the Northeast, according to FlightAware real-time data. Major hubs hit hardest: Airports ...

Last week, I noticed that my C: drive was running low on storage, with a little over 25GB of space left. First, I deleted a couple of large files from the Downloads folder, and it helped me reclaim ...

BEIJING -- The People's Bank of China has begun offering interest on its central bank digital currency, aiming to encourage use as an alternative to the dollar for cross-border transactions.

Elizabeth Blessing is a financial writer and editor specializing in growth investing, high-yield stocks, small caps, and gold investing. Thomas J. Brock is a CFA and CPA with more than 20 years of ...